Longford jobs blow as Abbott seeks 29 redundancies

Stefan Molitor, Site Director, Abbott Diagnostics Longford and Mairead Dalton, Abbott Diagnostics employee pictured before Christmas with a new Abbott test that may help doctors more accurately identify heart attacks in women. Abbott Diagnostics, Longford supported the development of the test and manufactures it for worldwide use. Picture Conor McCabe Photography.
There was some bad news on the jobs front yesterday, as Abbott Longford confirmed that they are seeking 29 redundancies.

There was some bad news on the jobs front yesterday, as Abbott Longford confirmed that they are seeking 29 redundancies.

In a press release issued by the company, it is said that “Abbott’s diagnostic division is seeking 29 redundancies at its Longford diagnostics facility as the division discontinues manufacture of AxSYM reagents and transitions to newer, next generation technologies.”

The company anticipates that the redundancies will be “achieved on a voluntary basis”.

“The company has begun to engage with employees on the proposed redundancies.

“The company will be offering favourable redundancy terms and outplacement services will be put in place to support impacted employees.

“Longford will continue to play a key role within Abbott’s global manufacturing network.”